Results 181 to 190 of about 4,153 (212)

Effect of Finerenone on Chronic Kidney Disease Outcomes in Type 2 Diabetes

New England Journal of Medicine, 2020
George Bakris, Rajiv Agarwal, Stefan D Anker   +2 more
exaly  

Blood Pressure and Cardiorenal Outcomes With Finerenone in Chronic Kidney Disease in Type 2 Diabetes

Hypertension, 2022
Luis Miguel Ruilope, Rajiv Agarwal, Stefan D Anker   +2 more
exaly  

Cardiovascular and kidney outcomes with finerenone in patients with type 2 diabetes and chronic kidney disease: the FIDELITY pooled analysis

European Heart Journal, 2022
Rajiv Agarwal, Gerasimos Filippatos, Bertram Pitt   +2 more
exaly  

Finerenone in Patients With Chronic Kidney Disease and Type 2 Diabetes According to Baseline HbA1c and Insulin Use: An Analysis From the FIDELIO-DKD Study

Diabetes Care, 2022
Chameleon Chameleon, Peter R Rossing, Rajiv Agarwal   +2 more
exaly  

Finerenone in chronic kidney disease

Nature Reviews Nephrology, 2020
openaire   +2 more sources

Design of the COmbinatioN effect of FInerenone anD EmpaglifloziN in participants with chronic kidney disease and type 2 diabetes using a UACR Endpoint study (CONFIDENCE)

Nephrology Dialysis Transplantation, 2023
Jennifer B Green, Amy K Mottl, George Bakris   +2 more
exaly  

Finerenon schützt Herz und Niere

MMW - Fortschritte der Medizin, 2022
openaire   +1 more source

CV benefits of finerenone in T2DM and CKD

Nature Reviews Cardiology, 2021
openaire   +2 more sources

▼Finerenone for CKD associated with type 2 diabetes

Drug and Therapeutics Bulletin, 2023
openaire   +2 more sources

Effect of Finerenone on Albuminuria in Patients With Diabetic Nephropathy

JAMA - Journal of the American Medical Association, 2015
George Bakris, Rajiv Agarwal, Ron T Gansevoort   +2 more
exaly